nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—colon cancer—Betamethasone—ulcerative colitis	0.221	0.366	CpDpCtD
Aprepitant—colon cancer—Dexamethasone—ulcerative colitis	0.221	0.366	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—ulcerative colitis	0.0811	0.134	CpDpCtD
Aprepitant—breast cancer—Betamethasone—ulcerative colitis	0.0811	0.134	CpDpCtD
Aprepitant—CYP3A4—Budesonide—ulcerative colitis	0.0191	0.0711	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Hydrocortisone—ulcerative colitis	0.0178	0.066	CbGbCtD
Aprepitant—CYP3A7—Hydrocortisone—ulcerative colitis	0.0178	0.066	CbGbCtD
Aprepitant—CYP2C19—Nicotine—ulcerative colitis	0.0172	0.064	CbGbCtD
Aprepitant—CYP3A5—Sulfasalazine—ulcerative colitis	0.0166	0.0617	CbGbCtD
Aprepitant—CYP1A2—Nicotine—ulcerative colitis	0.0159	0.0591	CbGbCtD
Aprepitant—CYP2C19—Cholecalciferol—ulcerative colitis	0.0155	0.0574	CbGbCtD
Aprepitant—CYP2C9—Nicotine—ulcerative colitis	0.0143	0.0532	CbGbCtD
Aprepitant—CYP3A5—Hydrocortisone—ulcerative colitis	0.0133	0.0495	CbGbCtD
Aprepitant—CYP2C9—Cholecalciferol—ulcerative colitis	0.0128	0.0477	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—ulcerative colitis	0.0111	0.0411	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—ulcerative colitis	0.0111	0.0411	CbGbCtD
Aprepitant—CYP2C19—Prednisone—ulcerative colitis	0.0107	0.0398	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—ulcerative colitis	0.00855	0.0317	CbGbCtD
Aprepitant—CYP3A4—Nicotine—ulcerative colitis	0.00833	0.0309	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—ulcerative colitis	0.00829	0.0308	CbGbCtD
Aprepitant—CYP3A4—Cholecalciferol—ulcerative colitis	0.00747	0.0278	CbGbCtD
Aprepitant—CYP2C19—Dexamethasone—ulcerative colitis	0.00669	0.0248	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—ulcerative colitis	0.00648	0.0241	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—ulcerative colitis	0.00556	0.0207	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—ulcerative colitis	0.00556	0.0206	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—ulcerative colitis	0.00548	0.0204	CbGbCtD
Aprepitant—CYP3A4—Hydrocortisone—ulcerative colitis	0.0052	0.0193	CbGbCtD
Aprepitant—CYP3A4—Prednisone—ulcerative colitis	0.00518	0.0192	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—ulcerative colitis	0.00323	0.012	CbGbCtD
Aprepitant—TACR3—Signaling by GPCR—CXCR1—ulcerative colitis	0.000147	0.00579	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000144	0.00566	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCL20—ulcerative colitis	0.000142	0.0056	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—ADRB2—ulcerative colitis	0.00014	0.00554	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TLR4—ulcerative colitis	0.00014	0.00552	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00014	0.00551	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000139	0.00548	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000135	0.00533	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—ICAM1—ulcerative colitis	0.000134	0.00529	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GNA12—ulcerative colitis	0.000133	0.00527	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000133	0.00524	CbGpPWpGaD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000132	0.0052	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000132	0.0052	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL20—ulcerative colitis	0.000129	0.00509	CbGpPWpGaD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000128	0.00504	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000126	0.00499	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL20—ulcerative colitis	0.000123	0.00484	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GNA12—ulcerative colitis	0.000121	0.00478	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCR6—ulcerative colitis	0.000119	0.00469	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000119	0.00469	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCR2—ulcerative colitis	0.000115	0.00453	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000109	0.00431	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000109	0.00429	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCR6—ulcerative colitis	0.000108	0.00426	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SEL1L—ulcerative colitis	0.000105	0.00416	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000105	0.00413	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCR6—ulcerative colitis	0.000103	0.00406	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IFNG—ulcerative colitis	0.000102	0.00403	CbGpPWpGaD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000102	0.00402	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000102	0.00402	CbGpPWpGaD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000102	0.00401	CbGpPWpGaD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000101	0.004	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—PTGS2—ulcerative colitis	9.79e-05	0.00386	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GHRL—ulcerative colitis	9.59e-05	0.00378	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PTGER4—ulcerative colitis	9.51e-05	0.00375	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CXCL8—ulcerative colitis	9.49e-05	0.00375	CbGpPWpGaD
Aprepitant—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	9.29e-05	0.00367	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	9.29e-05	0.00366	CbGpPWpGaD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	9.23e-05	0.00364	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL1B—ulcerative colitis	9.1e-05	0.00359	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL2—ulcerative colitis	9.07e-05	0.00358	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—PTGER4—ulcerative colitis	9.05e-05	0.00357	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	9e-05	0.00355	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	8.91e-05	0.00351	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.85e-05	0.00349	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.83e-05	0.00349	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GHRL—ulcerative colitis	8.7e-05	0.00344	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCR1—ulcerative colitis	8.67e-05	0.00342	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MMP9—ulcerative colitis	8.58e-05	0.00339	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CALM3—ulcerative colitis	8.43e-05	0.00333	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—GHRL—ulcerative colitis	8.28e-05	0.00327	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—ADRB2—ulcerative colitis	7.93e-05	0.00313	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	7.93e-05	0.00313	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCR1—ulcerative colitis	7.89e-05	0.00312	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	7.89e-05	0.00311	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL20—ulcerative colitis	7.61e-05	0.003	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	7.59e-05	0.003	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.56e-05	0.00298	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.55e-05	0.00298	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	7.28e-05	0.00287	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—ADRB2—ulcerative colitis	7.21e-05	0.00284	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCR1—ulcerative colitis	7.17e-05	0.00283	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GNA12—ulcerative colitis	7.16e-05	0.00282	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.13e-05	0.00282	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TGFB1—ulcerative colitis	7.08e-05	0.00279	CbGpPWpGaD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	6.97e-05	0.00275	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCL20—ulcerative colitis	6.93e-05	0.00273	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—ADRB2—ulcerative colitis	6.86e-05	0.00271	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	6.79e-05	0.00268	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCR2—ulcerative colitis	6.79e-05	0.00268	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—PTGS1—ulcerative colitis	6.78e-05	0.00268	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CXCL8—ulcerative colitis	6.78e-05	0.00268	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	6.76e-05	0.00267	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—ADCY5—ulcerative colitis	6.74e-05	0.00266	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TNF—ulcerative colitis	6.61e-05	0.00261	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—GNA12—ulcerative colitis	6.52e-05	0.00257	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.51e-05	0.00257	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	6.48e-05	0.00256	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	6.43e-05	0.00254	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCR6—ulcerative colitis	6.38e-05	0.00252	CbGpPWpGaD
Aprepitant—TACR3—smooth muscle tissue—ulcerative colitis	6.35e-05	0.349	CbGeAlD
Aprepitant—TACR1—Signaling by GPCR—CCL20—ulcerative colitis	6.29e-05	0.00248	CbGpPWpGaD
Aprepitant—Shock—Hydrocortisone—ulcerative colitis	6.25e-05	0.000617	CcSEcCtD
Aprepitant—Myalgia—Triamcinolone—ulcerative colitis	6.24e-05	0.000616	CcSEcCtD
Aprepitant—Vomiting—Azathioprine—ulcerative colitis	6.23e-05	0.000616	CcSEcCtD
Aprepitant—Nervous system disorder—Hydrocortisone—ulcerative colitis	6.23e-05	0.000615	CcSEcCtD
Aprepitant—Myalgia—Methylprednisolone—ulcerative colitis	6.22e-05	0.000615	CcSEcCtD
Aprepitant—Arthralgia—Methylprednisolone—ulcerative colitis	6.22e-05	0.000615	CcSEcCtD
Aprepitant—Eye disorder—Prednisone—ulcerative colitis	6.22e-05	0.000614	CcSEcCtD
Aprepitant—Anxiety—Methylprednisolone—ulcerative colitis	6.2e-05	0.000613	CcSEcCtD
Aprepitant—Tachycardia—Hydrocortisone—ulcerative colitis	6.2e-05	0.000612	CcSEcCtD
Aprepitant—Rash—Azathioprine—ulcerative colitis	6.18e-05	0.000611	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	6.18e-05	0.000611	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CXCR2—ulcerative colitis	6.18e-05	0.00244	CbGpPWpGaD
Aprepitant—Dermatitis—Azathioprine—ulcerative colitis	6.18e-05	0.00061	CcSEcCtD
Aprepitant—Flushing—Prednisone—ulcerative colitis	6.17e-05	0.00061	CcSEcCtD
Aprepitant—Skin disorder—Hydrocortisone—ulcerative colitis	6.17e-05	0.000609	CcSEcCtD
Aprepitant—Ill-defined disorder—Betamethasone—ulcerative colitis	6.17e-05	0.000609	CcSEcCtD
Aprepitant—Ill-defined disorder—Dexamethasone—ulcerative colitis	6.17e-05	0.000609	CcSEcCtD
Aprepitant—Discomfort—Triamcinolone—ulcerative colitis	6.16e-05	0.000609	CcSEcCtD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.16e-05	0.00243	CbGpPWpGaD
Aprepitant—Discomfort—Methylprednisolone—ulcerative colitis	6.15e-05	0.000608	CcSEcCtD
Aprepitant—Headache—Azathioprine—ulcerative colitis	6.14e-05	0.000607	CcSEcCtD
Aprepitant—Hyperhidrosis—Hydrocortisone—ulcerative colitis	6.14e-05	0.000607	CcSEcCtD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	6.13e-05	0.00242	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—ADCY5—ulcerative colitis	6.12e-05	0.00241	CbGpPWpGaD
Aprepitant—Diarrhoea—Mesalazine—ulcerative colitis	6.11e-05	0.000604	CcSEcCtD
Aprepitant—Dry mouth—Triamcinolone—ulcerative colitis	6.1e-05	0.000603	CcSEcCtD
Aprepitant—Angioedema—Betamethasone—ulcerative colitis	6.07e-05	0.0006	CcSEcCtD
Aprepitant—Angioedema—Dexamethasone—ulcerative colitis	6.07e-05	0.0006	CcSEcCtD
Aprepitant—Anorexia—Hydrocortisone—ulcerative colitis	6.05e-05	0.000598	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—MAML2—ulcerative colitis	6.05e-05	0.00239	CbGpPWpGaD
Aprepitant—Angiopathy—Prednisone—ulcerative colitis	6.03e-05	0.000596	CcSEcCtD
Aprepitant—Confusional state—Methylprednisolone—ulcerative colitis	6.02e-05	0.000594	CcSEcCtD
Aprepitant—Immune system disorder—Prednisone—ulcerative colitis	6.01e-05	0.000593	CcSEcCtD
Aprepitant—Malaise—Betamethasone—ulcerative colitis	6e-05	0.000592	CcSEcCtD
Aprepitant—Malaise—Dexamethasone—ulcerative colitis	6e-05	0.000592	CcSEcCtD
Aprepitant—Anaphylactic shock—Triamcinolone—ulcerative colitis	5.98e-05	0.000591	CcSEcCtD
Aprepitant—Oedema—Triamcinolone—ulcerative colitis	5.98e-05	0.000591	CcSEcCtD
Aprepitant—Anaphylactic shock—Methylprednisolone—ulcerative colitis	5.97e-05	0.000589	CcSEcCtD
Aprepitant—Syncope—Betamethasone—ulcerative colitis	5.96e-05	0.000589	CcSEcCtD
Aprepitant—Syncope—Dexamethasone—ulcerative colitis	5.96e-05	0.000589	CcSEcCtD
Aprepitant—Infection—Triamcinolone—ulcerative colitis	5.94e-05	0.000587	CcSEcCtD
Aprepitant—Hypotension—Hydrocortisone—ulcerative colitis	5.93e-05	0.000586	CcSEcCtD
Aprepitant—Infection—Methylprednisolone—ulcerative colitis	5.93e-05	0.000586	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—GNA12—ulcerative colitis	5.92e-05	0.00233	CbGpPWpGaD
Aprepitant—Dizziness—Mesalazine—ulcerative colitis	5.91e-05	0.000583	CcSEcCtD
Aprepitant—Shock—Triamcinolone—ulcerative colitis	5.88e-05	0.000581	CcSEcCtD
Aprepitant—Insomnia—Prednisolone—ulcerative colitis	5.88e-05	0.000581	CcSEcCtD
Aprepitant—Alopecia—Prednisone—ulcerative colitis	5.88e-05	0.000581	CcSEcCtD
Aprepitant—Shock—Methylprednisolone—ulcerative colitis	5.87e-05	0.00058	CcSEcCtD
Aprepitant—Nervous system disorder—Methylprednisolone—ulcerative colitis	5.85e-05	0.000578	CcSEcCtD
Aprepitant—Loss of consciousness—Dexamethasone—ulcerative colitis	5.84e-05	0.000577	CcSEcCtD
Aprepitant—Loss of consciousness—Betamethasone—ulcerative colitis	5.84e-05	0.000577	CcSEcCtD
Aprepitant—Paraesthesia—Prednisolone—ulcerative colitis	5.84e-05	0.000577	CcSEcCtD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	5.84e-05	0.0023	CbGpPWpGaD
Aprepitant—Tachycardia—Triamcinolone—ulcerative colitis	5.84e-05	0.000577	CcSEcCtD
Aprepitant—Mental disorder—Prednisone—ulcerative colitis	5.83e-05	0.000576	CcSEcCtD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	5.83e-05	0.0023	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TP53—ulcerative colitis	5.82e-05	0.0023	CbGpPWpGaD
Aprepitant—Nausea—Azathioprine—ulcerative colitis	5.82e-05	0.000575	CcSEcCtD
Aprepitant—Tachycardia—Methylprednisolone—ulcerative colitis	5.82e-05	0.000575	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CCR6—ulcerative colitis	5.81e-05	0.00229	CbGpPWpGaD
Aprepitant—Skin disorder—Methylprednisolone—ulcerative colitis	5.8e-05	0.000573	CcSEcCtD
Aprepitant—Malnutrition—Prednisone—ulcerative colitis	5.79e-05	0.000572	CcSEcCtD
Aprepitant—Erythema—Prednisone—ulcerative colitis	5.79e-05	0.000572	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	5.79e-05	0.000572	CcSEcCtD
Aprepitant—Hyperhidrosis—Triamcinolone—ulcerative colitis	5.78e-05	0.000571	CcSEcCtD
Aprepitant—Hyperhidrosis—Methylprednisolone—ulcerative colitis	5.77e-05	0.00057	CcSEcCtD
Aprepitant—Convulsion—Betamethasone—ulcerative colitis	5.76e-05	0.000569	CcSEcCtD
Aprepitant—Convulsion—Dexamethasone—ulcerative colitis	5.76e-05	0.000569	CcSEcCtD
Aprepitant—Insomnia—Hydrocortisone—ulcerative colitis	5.74e-05	0.000567	CcSEcCtD
Aprepitant—Hypertension—Dexamethasone—ulcerative colitis	5.74e-05	0.000567	CcSEcCtD
Aprepitant—Hypertension—Betamethasone—ulcerative colitis	5.74e-05	0.000567	CcSEcCtD
Aprepitant—Paraesthesia—Hydrocortisone—ulcerative colitis	5.7e-05	0.000563	CcSEcCtD
Aprepitant—Vomiting—Mesalazine—ulcerative colitis	5.68e-05	0.000561	CcSEcCtD
Aprepitant—Myalgia—Betamethasone—ulcerative colitis	5.66e-05	0.000559	CcSEcCtD
Aprepitant—Myalgia—Dexamethasone—ulcerative colitis	5.66e-05	0.000559	CcSEcCtD
Aprepitant—Anxiety—Betamethasone—ulcerative colitis	5.64e-05	0.000557	CcSEcCtD
Aprepitant—Anxiety—Dexamethasone—ulcerative colitis	5.64e-05	0.000557	CcSEcCtD
Aprepitant—Rash—Mesalazine—ulcerative colitis	5.63e-05	0.000556	CcSEcCtD
Aprepitant—Dermatitis—Mesalazine—ulcerative colitis	5.63e-05	0.000556	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—PTGER4—ulcerative colitis	5.62e-05	0.00222	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCR2—ulcerative colitis	5.61e-05	0.00221	CbGpPWpGaD
Aprepitant—Headache—Mesalazine—ulcerative colitis	5.6e-05	0.000553	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—ulcerative colitis	5.59e-05	0.000552	CcSEcCtD
Aprepitant—Discomfort—Dexamethasone—ulcerative colitis	5.59e-05	0.000552	CcSEcCtD
Aprepitant—Dyspepsia—Hydrocortisone—ulcerative colitis	5.59e-05	0.000552	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—ulcerative colitis	5.58e-05	0.000551	CcSEcCtD
Aprepitant—Pain—Prednisolone—ulcerative colitis	5.56e-05	0.000549	CcSEcCtD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.56e-05	0.00219	CbGpPWpGaD
Aprepitant—Decreased appetite—Hydrocortisone—ulcerative colitis	5.52e-05	0.000545	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	5.48e-05	0.000542	CcSEcCtD
Aprepitant—Fatigue—Hydrocortisone—ulcerative colitis	5.48e-05	0.000541	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	5.45e-05	0.000538	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	5.44e-05	0.000537	CcSEcCtD
Aprepitant—Pain—Hydrocortisone—ulcerative colitis	5.43e-05	0.000537	CcSEcCtD
Aprepitant—Oedema—Betamethasone—ulcerative colitis	5.43e-05	0.000536	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—ulcerative colitis	5.43e-05	0.000536	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—ulcerative colitis	5.43e-05	0.000536	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—ulcerative colitis	5.43e-05	0.000536	CcSEcCtD
Aprepitant—Insomnia—Triamcinolone—ulcerative colitis	5.41e-05	0.000534	CcSEcCtD
Aprepitant—Insomnia—Methylprednisolone—ulcerative colitis	5.4e-05	0.000533	CcSEcCtD
Aprepitant—Infection—Betamethasone—ulcerative colitis	5.39e-05	0.000533	CcSEcCtD
Aprepitant—Infection—Dexamethasone—ulcerative colitis	5.39e-05	0.000533	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisone—ulcerative colitis	5.37e-05	0.000531	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—ulcerative colitis	5.37e-05	0.00053	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—ulcerative colitis	5.36e-05	0.000529	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—ulcerative colitis	5.36e-05	0.000529	CcSEcCtD
Aprepitant—Anaemia—Prednisone—ulcerative colitis	5.35e-05	0.000529	CcSEcCtD
Aprepitant—Shock—Betamethasone—ulcerative colitis	5.34e-05	0.000527	CcSEcCtD
Aprepitant—Shock—Dexamethasone—ulcerative colitis	5.34e-05	0.000527	CcSEcCtD
Aprepitant—Dyspnoea—Triamcinolone—ulcerative colitis	5.33e-05	0.000527	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—IL6—ulcerative colitis	5.33e-05	0.0021	CbGpPWpGaD
Aprepitant—Nervous system disorder—Dexamethasone—ulcerative colitis	5.32e-05	0.000526	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—ulcerative colitis	5.32e-05	0.000526	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—ulcerative colitis	5.31e-05	0.000525	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—ulcerative colitis	5.31e-05	0.000525	CcSEcCtD
Aprepitant—Nausea—Mesalazine—ulcerative colitis	5.31e-05	0.000524	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—ulcerative colitis	5.3e-05	0.000523	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—ulcerative colitis	5.3e-05	0.000523	CcSEcCtD
Aprepitant—Angioedema—Prednisone—ulcerative colitis	5.29e-05	0.000523	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TNF—ulcerative colitis	5.28e-05	0.00209	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCR6—ulcerative colitis	5.27e-05	0.00208	CbGpPWpGaD
Aprepitant—Dyspepsia—Triamcinolone—ulcerative colitis	5.26e-05	0.00052	CcSEcCtD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.26e-05	0.00208	CbGpPWpGaD
Aprepitant—Dyspepsia—Methylprednisolone—ulcerative colitis	5.25e-05	0.000519	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—ulcerative colitis	5.25e-05	0.000518	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—ulcerative colitis	5.25e-05	0.000518	CcSEcCtD
Aprepitant—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.24e-05	0.00207	CbGpPWpGaD
Aprepitant—Feeling abnormal—Hydrocortisone—ulcerative colitis	5.23e-05	0.000517	CcSEcCtD
Aprepitant—Malaise—Prednisone—ulcerative colitis	5.22e-05	0.000516	CcSEcCtD
Aprepitant—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	5.19e-05	0.000513	CcSEcCtD
Aprepitant—Syncope—Prednisone—ulcerative colitis	5.19e-05	0.000513	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—ulcerative colitis	5.17e-05	0.000511	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—ulcerative colitis	5.17e-05	0.000511	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—ulcerative colitis	5.17e-05	0.00051	CcSEcCtD
Aprepitant—Fatigue—Triamcinolone—ulcerative colitis	5.16e-05	0.000509	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—ulcerative colitis	5.14e-05	0.000508	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—SEL1L—ulcerative colitis	5.14e-05	0.00203	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GHRL—ulcerative colitis	5.14e-05	0.00203	CbGpPWpGaD
Aprepitant—Pain—Triamcinolone—ulcerative colitis	5.11e-05	0.000505	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—PTGER4—ulcerative colitis	5.11e-05	0.00202	CbGpPWpGaD
Aprepitant—Loss of consciousness—Prednisone—ulcerative colitis	5.09e-05	0.000503	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—ulcerative colitis	5.07e-05	0.000501	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—ulcerative colitis	5.07e-05	0.000501	CcSEcCtD
Aprepitant—Urticaria—Hydrocortisone—ulcerative colitis	5.05e-05	0.000498	CcSEcCtD
Aprepitant—Body temperature increased—Hydrocortisone—ulcerative colitis	5.02e-05	0.000496	CcSEcCtD
Aprepitant—Abdominal pain—Hydrocortisone—ulcerative colitis	5.02e-05	0.000496	CcSEcCtD
Aprepitant—Convulsion—Prednisone—ulcerative colitis	5.02e-05	0.000496	CcSEcCtD
Aprepitant—Hypertension—Prednisone—ulcerative colitis	5e-05	0.000494	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CALM3—ulcerative colitis	4.98e-05	0.00197	CbGpPWpGaD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.94e-05	0.000488	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.94e-05	0.000488	CcSEcCtD
Aprepitant—Arthralgia—Prednisone—ulcerative colitis	4.93e-05	0.000487	CcSEcCtD
Aprepitant—Myalgia—Prednisone—ulcerative colitis	4.93e-05	0.000487	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—ulcerative colitis	4.93e-05	0.000487	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.92e-05	0.000486	CcSEcCtD
Aprepitant—Anxiety—Prednisone—ulcerative colitis	4.91e-05	0.000485	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—ulcerative colitis	4.91e-05	0.000485	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—ulcerative colitis	4.91e-05	0.000485	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—RIPK2—ulcerative colitis	4.91e-05	0.00194	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	4.9e-05	0.00193	CbGpPWpGaD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	4.9e-05	0.000484	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.88e-05	0.000482	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—ulcerative colitis	4.87e-05	0.000481	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—ulcerative colitis	4.87e-05	0.000481	CcSEcCtD
Aprepitant—Discomfort—Prednisone—ulcerative colitis	4.87e-05	0.000481	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisolone—ulcerative colitis	4.79e-05	0.000473	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—ulcerative colitis	4.78e-05	0.000472	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—ulcerative colitis	4.78e-05	0.000472	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—ulcerative colitis	4.75e-05	0.000469	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—ulcerative colitis	4.74e-05	0.000468	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—ulcerative colitis	4.73e-05	0.000467	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisone—ulcerative colitis	4.73e-05	0.000467	CcSEcCtD
Aprepitant—Oedema—Prednisone—ulcerative colitis	4.73e-05	0.000467	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—ulcerative colitis	4.72e-05	0.000466	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—ulcerative colitis	4.72e-05	0.000466	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—ulcerative colitis	4.72e-05	0.000466	CcSEcCtD
Aprepitant—Infection—Prednisone—ulcerative colitis	4.69e-05	0.000464	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betamethasone—ulcerative colitis	4.68e-05	0.000463	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	4.68e-05	0.000463	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—GHRL—ulcerative colitis	4.68e-05	0.00185	CbGpPWpGaD
Aprepitant—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.68e-05	0.000462	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—ulcerative colitis	4.68e-05	0.000462	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—ulcerative colitis	4.68e-05	0.000462	CcSEcCtD
Aprepitant—Shock—Prednisone—ulcerative colitis	4.65e-05	0.000459	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—PTGER4—ulcerative colitis	4.64e-05	0.00183	CbGpPWpGaD
Aprepitant—Pain—Betamethasone—ulcerative colitis	4.64e-05	0.000458	CcSEcCtD
Aprepitant—Pain—Dexamethasone—ulcerative colitis	4.64e-05	0.000458	CcSEcCtD
Aprepitant—Nervous system disorder—Prednisone—ulcerative colitis	4.63e-05	0.000458	CcSEcCtD
Aprepitant—Tachycardia—Prednisone—ulcerative colitis	4.61e-05	0.000456	CcSEcCtD
Aprepitant—Skin disorder—Prednisone—ulcerative colitis	4.59e-05	0.000453	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisone—ulcerative colitis	4.57e-05	0.000451	CcSEcCtD
Aprepitant—Asthenia—Hydrocortisone—ulcerative colitis	4.56e-05	0.00045	CcSEcCtD
Aprepitant—Anorexia—Prednisone—ulcerative colitis	4.5e-05	0.000445	CcSEcCtD
Aprepitant—Pruritus—Hydrocortisone—ulcerative colitis	4.49e-05	0.000444	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—ulcerative colitis	4.47e-05	0.000442	CcSEcCtD
Aprepitant—Feeling abnormal—Betamethasone—ulcerative colitis	4.47e-05	0.000442	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—ulcerative colitis	4.44e-05	0.000438	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—ulcerative colitis	4.44e-05	0.000438	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—ulcerative colitis	4.41e-05	0.000435	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—ulcerative colitis	4.4e-05	0.000434	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	4.35e-05	0.00172	CbGpPWpGaD
Aprepitant—Diarrhoea—Hydrocortisone—ulcerative colitis	4.35e-05	0.000429	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—ulcerative colitis	4.31e-05	0.000426	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—ulcerative colitis	4.31e-05	0.000426	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Prednisone—ulcerative colitis	4.31e-05	0.000425	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—ulcerative colitis	4.3e-05	0.000425	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—ulcerative colitis	4.29e-05	0.000424	CcSEcCtD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.29e-05	0.00169	CbGpPWpGaD
Aprepitant—Body temperature increased—Betamethasone—ulcerative colitis	4.29e-05	0.000424	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—ulcerative colitis	4.29e-05	0.000424	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—ulcerative colitis	4.29e-05	0.000424	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—ulcerative colitis	4.29e-05	0.000424	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—ulcerative colitis	4.28e-05	0.000423	CcSEcCtD
Aprepitant—Insomnia—Prednisone—ulcerative colitis	4.27e-05	0.000422	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL6—ulcerative colitis	4.26e-05	0.00168	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ADRB2—ulcerative colitis	4.26e-05	0.00168	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GHRL—ulcerative colitis	4.25e-05	0.00168	CbGpPWpGaD
Aprepitant—Paraesthesia—Prednisone—ulcerative colitis	4.24e-05	0.000419	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CXCR1—ulcerative colitis	4.23e-05	0.00167	CbGpPWpGaD
Aprepitant—Pruritus—Triamcinolone—ulcerative colitis	4.23e-05	0.000418	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—ulcerative colitis	4.22e-05	0.000417	CcSEcCtD
Aprepitant—Dizziness—Hydrocortisone—ulcerative colitis	4.2e-05	0.000415	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—JAK2—ulcerative colitis	4.2e-05	0.00166	CbGpPWpGaD
Aprepitant—Dyspepsia—Prednisone—ulcerative colitis	4.16e-05	0.000411	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—CALM3—ulcerative colitis	4.12e-05	0.00162	CbGpPWpGaD
Aprepitant—Decreased appetite—Prednisone—ulcerative colitis	4.11e-05	0.000406	CcSEcCtD
Aprepitant—Rash—Prednisolone—ulcerative colitis	4.1e-05	0.000405	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—ulcerative colitis	4.1e-05	0.000405	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—ulcerative colitis	4.08e-05	0.000403	CcSEcCtD
Aprepitant—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	4.08e-05	0.00161	CbGpPWpGaD
Aprepitant—Fatigue—Prednisone—ulcerative colitis	4.07e-05	0.000402	CcSEcCtD
Aprepitant—Headache—Prednisolone—ulcerative colitis	4.07e-05	0.000402	CcSEcCtD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	4.06e-05	0.0016	CbGpPWpGaD
Aprepitant—Constipation—Prednisone—ulcerative colitis	4.04e-05	0.000399	CcSEcCtD
Aprepitant—Vomiting—Hydrocortisone—ulcerative colitis	4.04e-05	0.000399	CcSEcCtD
Aprepitant—Rash—Hydrocortisone—ulcerative colitis	4e-05	0.000396	CcSEcCtD
Aprepitant—Dermatitis—Hydrocortisone—ulcerative colitis	4e-05	0.000395	CcSEcCtD
Aprepitant—Headache—Hydrocortisone—ulcerative colitis	3.98e-05	0.000393	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—ulcerative colitis	3.95e-05	0.000391	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—ulcerative colitis	3.95e-05	0.00039	CcSEcCtD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.9e-05	0.00154	CbGpPWpGaD
Aprepitant—Feeling abnormal—Prednisone—ulcerative colitis	3.89e-05	0.000385	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—ulcerative colitis	3.89e-05	0.000385	CcSEcCtD
Aprepitant—Asthenia—Dexamethasone—ulcerative colitis	3.89e-05	0.000385	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—ADRB2—ulcerative colitis	3.88e-05	0.00153	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Prednisone—ulcerative colitis	3.86e-05	0.000382	CcSEcCtD
Aprepitant—Nausea—Prednisolone—ulcerative colitis	3.86e-05	0.000382	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—ulcerative colitis	3.84e-05	0.000379	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—ulcerative colitis	3.84e-05	0.000379	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—CXCL8—ulcerative colitis	3.83e-05	0.00151	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—JAK2—ulcerative colitis	3.81e-05	0.0015	CbGpPWpGaD
Aprepitant—Vomiting—Triamcinolone—ulcerative colitis	3.8e-05	0.000376	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—ulcerative colitis	3.79e-05	0.000375	CcSEcCtD
Aprepitant—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	3.79e-05	0.0015	CbGpPWpGaD
Aprepitant—Nausea—Hydrocortisone—ulcerative colitis	3.77e-05	0.000373	CcSEcCtD
Aprepitant—Rash—Triamcinolone—ulcerative colitis	3.77e-05	0.000372	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—ulcerative colitis	3.77e-05	0.000372	CcSEcCtD
Aprepitant—Rash—Methylprednisolone—ulcerative colitis	3.76e-05	0.000372	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—ulcerative colitis	3.76e-05	0.000371	CcSEcCtD
Aprepitant—Urticaria—Prednisone—ulcerative colitis	3.75e-05	0.000371	CcSEcCtD
Aprepitant—Headache—Triamcinolone—ulcerative colitis	3.75e-05	0.00037	CcSEcCtD
Aprepitant—Headache—Methylprednisolone—ulcerative colitis	3.74e-05	0.000369	CcSEcCtD
Aprepitant—Abdominal pain—Prednisone—ulcerative colitis	3.74e-05	0.000369	CcSEcCtD
Aprepitant—Body temperature increased—Prednisone—ulcerative colitis	3.74e-05	0.000369	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CCL20—ulcerative colitis	3.72e-05	0.00147	CbGpPWpGaD
Aprepitant—Diarrhoea—Dexamethasone—ulcerative colitis	3.71e-05	0.000367	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—ulcerative colitis	3.71e-05	0.000367	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—IL2—ulcerative colitis	3.66e-05	0.00145	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ADCY5—ulcerative colitis	3.61e-05	0.00143	CbGpPWpGaD
Aprepitant—Dizziness—Betamethasone—ulcerative colitis	3.59e-05	0.000354	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—ulcerative colitis	3.59e-05	0.000354	CcSEcCtD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.56e-05	0.0014	CbGpPWpGaD
Aprepitant—Nausea—Triamcinolone—ulcerative colitis	3.55e-05	0.000351	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—ulcerative colitis	3.54e-05	0.00035	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—ADRB2—ulcerative colitis	3.52e-05	0.00139	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNA12—ulcerative colitis	3.5e-05	0.00138	CbGpPWpGaD
Aprepitant—Hypersensitivity—Prednisone—ulcerative colitis	3.48e-05	0.000344	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—CXCL8—ulcerative colitis	3.48e-05	0.00137	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	3.46e-05	0.00136	CbGpPWpGaD
Aprepitant—Vomiting—Dexamethasone—ulcerative colitis	3.45e-05	0.000341	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—ulcerative colitis	3.45e-05	0.000341	CcSEcCtD
Aprepitant—Rash—Betamethasone—ulcerative colitis	3.42e-05	0.000338	CcSEcCtD
Aprepitant—Rash—Dexamethasone—ulcerative colitis	3.42e-05	0.000338	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—ulcerative colitis	3.42e-05	0.000338	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—ulcerative colitis	3.42e-05	0.000338	CcSEcCtD
Aprepitant—Headache—Dexamethasone—ulcerative colitis	3.4e-05	0.000336	CcSEcCtD
Aprepitant—Headache—Betamethasone—ulcerative colitis	3.4e-05	0.000336	CcSEcCtD
Aprepitant—Asthenia—Prednisone—ulcerative colitis	3.39e-05	0.000335	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	3.39e-05	0.00134	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.35e-05	0.00132	CbGpPWpGaD
Aprepitant—Pruritus—Prednisone—ulcerative colitis	3.34e-05	0.00033	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—IL2—ulcerative colitis	3.33e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCR2—ulcerative colitis	3.31e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL8—ulcerative colitis	3.31e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.3e-05	0.0013	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—ADCY5—ulcerative colitis	3.29e-05	0.0013	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.25e-05	0.00128	CbGpPWpGaD
Aprepitant—Diarrhoea—Prednisone—ulcerative colitis	3.23e-05	0.000319	CcSEcCtD
Aprepitant—Nausea—Dexamethasone—ulcerative colitis	3.22e-05	0.000318	CcSEcCtD
Aprepitant—Nausea—Betamethasone—ulcerative colitis	3.22e-05	0.000318	CcSEcCtD
Aprepitant—Dizziness—Prednisone—ulcerative colitis	3.12e-05	0.000309	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CCR6—ulcerative colitis	3.12e-05	0.00123	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.04e-05	0.0012	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.02e-05	0.00119	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.01e-05	0.00119	CbGpPWpGaD
Aprepitant—Vomiting—Prednisone—ulcerative colitis	3e-05	0.000297	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—ADCY5—ulcerative colitis	2.99e-05	0.00118	CbGpPWpGaD
Aprepitant—Rash—Prednisone—ulcerative colitis	2.98e-05	0.000294	CcSEcCtD
Aprepitant—Dermatitis—Prednisone—ulcerative colitis	2.98e-05	0.000294	CcSEcCtD
Aprepitant—Headache—Prednisone—ulcerative colitis	2.96e-05	0.000292	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—MAML2—ulcerative colitis	2.95e-05	0.00117	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	2.95e-05	0.00117	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.82e-05	0.00111	CbGpPWpGaD
Aprepitant—Nausea—Prednisone—ulcerative colitis	2.81e-05	0.000277	CcSEcCtD
Aprepitant—CYP3A7—Metabolism—CHP1—ulcerative colitis	2.78e-05	0.0011	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTGER4—ulcerative colitis	2.74e-05	0.00108	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GHRL—ulcerative colitis	2.51e-05	0.000991	CbGpPWpGaD
Aprepitant—TACR1—smooth muscle tissue—ulcerative colitis	2.46e-05	0.135	CbGeAlD
Aprepitant—TACR1—Signaling Pathways—CALM3—ulcerative colitis	2.43e-05	0.00096	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—DLD—ulcerative colitis	2.4e-05	0.000947	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RIPK2—ulcerative colitis	2.4e-05	0.000945	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.35e-05	0.000927	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.28e-05	0.000899	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—JAK2—ulcerative colitis	2.25e-05	0.000889	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.19e-05	0.000866	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.19e-05	0.000866	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RELA—ulcerative colitis	2.18e-05	0.000861	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ADRB2—ulcerative colitis	2.08e-05	0.00082	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL8—ulcerative colitis	2.06e-05	0.000811	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—JAK2—ulcerative colitis	2.05e-05	0.000809	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CHP1—ulcerative colitis	2.01e-05	0.000793	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—ulcerative colitis	1.96e-05	0.000775	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—ulcerative colitis	1.95e-05	0.000771	CbGpPWpGaD
Aprepitant—TACR1—digestive system—ulcerative colitis	1.94e-05	0.107	CbGeAlD
Aprepitant—TACR1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.87e-05	0.000739	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—JAK2—ulcerative colitis	1.86e-05	0.000735	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—ulcerative colitis	1.86e-05	0.000734	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NFKB1—ulcerative colitis	1.84e-05	0.000726	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—ulcerative colitis	1.79e-05	0.000706	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ADCY5—ulcerative colitis	1.76e-05	0.000696	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—DLD—ulcerative colitis	1.73e-05	0.000684	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL8—ulcerative colitis	1.7e-05	0.000671	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—STAT3—ulcerative colitis	1.65e-05	0.000652	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—ulcerative colitis	1.62e-05	0.000641	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CHP1—ulcerative colitis	1.55e-05	0.000613	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—ulcerative colitis	1.53e-05	0.000605	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.46e-05	0.000574	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.42e-05	0.000559	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—DLD—ulcerative colitis	1.34e-05	0.000529	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.33e-05	0.000524	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—ulcerative colitis	1.26e-05	0.000498	CbGpPWpGaD
Aprepitant—CYP3A7—liver—ulcerative colitis	1.24e-05	0.068	CbGeAlD
Aprepitant—CYP2C9—Metabolism—DLD—ulcerative colitis	1.22e-05	0.000482	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.21e-05	0.000478	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS1—ulcerative colitis	1.16e-05	0.000458	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—ulcerative colitis	1.15e-05	0.000456	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.13e-05	0.000447	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—JAK2—ulcerative colitis	1.1e-05	0.000434	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RELA—ulcerative colitis	1.07e-05	0.00042	CbGpPWpGaD
Aprepitant—CYP3A7-CYP3A51P—liver—ulcerative colitis	1.05e-05	0.0578	CbGeAlD
Aprepitant—CYP1A2—Metabolism—DLD—ulcerative colitis	1.04e-05	0.000412	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CALM3—ulcerative colitis	1.04e-05	0.000412	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—ulcerative colitis	1e-05	0.000396	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—ulcerative colitis	9.59e-06	0.000379	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—ulcerative colitis	9.55e-06	0.000377	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.34e-06	0.000369	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—ulcerative colitis	9.08e-06	0.000358	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—ulcerative colitis	8.98e-06	0.000355	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS1—ulcerative colitis	8.38e-06	0.000331	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB1—ulcerative colitis	8.12e-06	0.00032	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—ulcerative colitis	8.07e-06	0.000319	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DLD—ulcerative colitis	8.06e-06	0.000318	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ADCY5—ulcerative colitis	7.58e-06	0.000299	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CALM3—ulcerative colitis	7.55e-06	0.000298	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—ulcerative colitis	7.48e-06	0.000295	CbGpPWpGaD
Aprepitant—CYP2C19—digestive system—ulcerative colitis	7.42e-06	0.0408	CbGeAlD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.09e-06	0.00028	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.48e-06	0.000256	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.46e-06	0.000255	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.37e-06	0.000252	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—ulcerative colitis	6.16e-06	0.000243	CbGpPWpGaD
Aprepitant—CYP1A2—digestive system—ulcerative colitis	6.06e-06	0.0333	CbGeAlD
Aprepitant—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.91e-06	0.000233	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—ulcerative colitis	5.87e-06	0.000232	CbGpPWpGaD
Aprepitant—CYP3A5—digestive system—ulcerative colitis	5.84e-06	0.0321	CbGeAlD
Aprepitant—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.84e-06	0.00023	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.81e-06	0.000229	CbGpPWpGaD
Aprepitant—CYP2C9—digestive system—ulcerative colitis	5.75e-06	0.0316	CbGeAlD
Aprepitant—CYP3A7—Metabolism—PPARG—ulcerative colitis	5.65e-06	0.000223	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—ulcerative colitis	5.64e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.58e-06	0.00022	CbGpPWpGaD
Aprepitant—CYP2C19—liver—ulcerative colitis	5.53e-06	0.0304	CbGeAlD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.52e-06	0.000218	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ADCY5—ulcerative colitis	5.48e-06	0.000216	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.32e-06	0.00021	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.09e-06	0.000201	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—ulcerative colitis	5.08e-06	0.0002	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.05e-06	0.000199	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.97e-06	0.000196	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.55e-06	0.000179	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.54e-06	0.000179	CbGpPWpGaD
Aprepitant—CYP1A2—liver—ulcerative colitis	4.51e-06	0.0248	CbGeAlD
Aprepitant—CYP3A7—Metabolism—PTGS2—ulcerative colitis	4.44e-06	0.000175	CbGpPWpGaD
Aprepitant—CYP3A4—digestive system—ulcerative colitis	4.39e-06	0.0241	CbGeAlD
Aprepitant—CYP3A5—liver—ulcerative colitis	4.35e-06	0.0239	CbGeAlD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.35e-06	0.000171	CbGpPWpGaD
Aprepitant—CYP2C9—liver—ulcerative colitis	4.28e-06	0.0236	CbGeAlD
Aprepitant—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.23e-06	0.000167	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.14e-06	0.000163	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—ulcerative colitis	4.08e-06	0.000161	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.9e-06	0.000154	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.86e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—ulcerative colitis	3.67e-06	0.000145	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.54e-06	0.00014	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.51e-06	0.000138	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.3e-06	0.00013	CbGpPWpGaD
Aprepitant—CYP3A4—liver—ulcerative colitis	3.27e-06	0.018	CbGeAlD
Aprepitant—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.21e-06	0.000127	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.16e-06	0.000125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.88e-06	0.000114	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—ulcerative colitis	2.84e-06	0.000112	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.73e-06	0.000108	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—ulcerative colitis	2.59e-06	0.000102	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.55e-06	0.0001	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.48e-06	9.8e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.46e-06	9.71e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.26e-06	8.94e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—ulcerative colitis	2.21e-06	8.73e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.94e-06	7.64e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.9e-06	7.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—ulcerative colitis	1.71e-06	6.74e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.49e-06	5.89e-05	CbGpPWpGaD
